Kalia Kumud 4
4 · Guardant Health, Inc. · Filed Mar 17, 2026
Research Summary
AI-generated summary of this filing
Guardant Health (GH) CIO Kalia Kumud Receives Vested RSUs
What Happened
Kalia Kumud, Chief Information Officer of Guardant Health (GH), received 13,493 shares when restricted stock units vested on March 15, 2026 (12,856 + 637 shares acquired at $0.00). To satisfy tax withholding, the company retained 6,839 of those shares at $85.49 per share, totaling $584,666. Net shares delivered to Kumud were 6,654 shares. This transaction represents the vesting/settlement of compensation awards rather than an open-market buy or sale.
Key Details
- Transaction date: March 15, 2026; Form 4 filed March 17, 2026.
- Acquired: 13,493 shares via RSU vesting (12,856 and 637 shares reported as conversion/exercise at $0.00).
- Withheld for taxes (disposed): 6,839 shares at $85.49/share = $584,666 (payment of tax liability).
- Net shares delivered to insider: 6,654 shares.
- Shares owned after transaction: Not reported on this Form 4.
- Footnotes: F2 = performance-based RSU (granted June 7, 2023) whose second tranche vested on March 15, 2026; F4 = time-based RSU (granted June 9, 2023) with multi-year vesting; F1 = shares were retained by the company solely to satisfy tax withholding and not in excess of the tax liability.
- Codes: M indicates conversion/exercise of a derivative (here the RSU settlement), F indicates tax withholding.
- Filing timeliness: No late filing is indicated on the Form 4 (filed March 17, 2026).
Context
This is a routine compensation event (RSU vesting) common for executives and not an open-market purchase or discretionary sale. The withholding of shares to cover taxes is a standard practice (similar to a "cashless" settlement) and should be viewed as a payroll/tax action rather than an indicator of buying or selling intent.
Insider Transaction Report
- Exercise/Conversion
Common Stock
2026-03-15+12,856→ 50,499 total - Exercise/Conversion
Common Stock
2026-03-15+637→ 51,136 total - Tax Payment
Common Stock
[F1]2026-03-15$85.49/sh−6,839$584,666→ 44,297 total - Exercise/Conversion
Performance-Based Restricted Stock Units
[F2][F3]2026-03-15−12,856→ 0 totalExercise: $0.00→ Common Stock (12,856 underlying) - Exercise/Conversion
Restricted Stock Units
[F4][F3]2026-03-15−637→ 638 totalExercise: $0.00→ Common Stock (637 underlying)
Footnotes (4)
- [F1]These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
- [F2]This represents a performance-based restricted stock unit award granted on June 7, 2023 with a 3-year performance metric. The second tranche metric was achieved and the shares vested on March 15, 2026.
- [F3]Not applicable for Restricted Stock Units.
- [F4]This represents a restricted stock unit award granted on June 9, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on June 15, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.